Bibliometric analysis of the global publication activity in the field of relapsing polychondritis during 1960-2023

© 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR)..

BACKGROUND: Relapsing polychondritis (RP) is an inflammatory disease with significant individual heterogeneity that involves systemic cartilage tissues. This study aimed to perform a bibliometric analysis of RP-related publications to quantitatively assess the scholarly productivity in the field.

METHODS: We extracted the RP-related original research articles and reviews published during 1960-2023 from the Web of Science database by using the keyword "relapsing polychondritis." By using R, CiteSpace, VOSviewer, and SCImago Graphica, the bibliometric analysis was performed on the retrieved publications.

RESULTS: A total of 1096 articles, consisting of 909 original research articles and 187 reviews, were identified. A mean annual growth rate of 6.71% was found in the number of RP-related publications during 1960-2022. The United States accounted for the highest number of publications (21.9%), exhibited the highest mean citation number per publication (40.7), and engaged in the most frequent academic collaboration. Three clusters of RP-related journals were identified: 1) otology, rhinology, and laryngology; 2) respiratory and radiology medicine; and 3) rheumatology. Journals with a focus on rheumatology issued the most publications, and most of the RP-related publications were from The Journal of Rheumatology (n = 27). Most of these publications were co-authored by Dr. Jean-Charles Piette (n = 19), who also had the highest H-index (13) among all the authors. The co-citation network analysis revealed 11 highly connected clusters of RP research and indicated the "VEXAS Syndrome" as a hotspot.

CONCLUSION: This overview of the RP research field comprehensively describes the progress in the field. The number of publications on RP has progressively increased but remains insufficient. The United States and European countries are at the forefront of RP-related research, and the journals related to rheumatology have covered the majority of publications. Additionally, several key topics for future investigations, such as "VEXAS Syndrome," have been identified. Key Points •We identified a mean annual growth rate of 6.71% in the number of the RP-related publications during 1960-2022. •The United States accounted for the majority of the publications, exhibited the highest mean citation number per publication, and engaged in the most frequent academic collaborations. •The journals of the publications were categorized into three clusters of research areas: 1) otology, rhinology, and laryngology; 2) respiratory and radiology medicine; and 3) rheumatology. Journals related to rheumatology issued the most publications, and most of the publications were from The Journal of Rheumatology •Most of the publications were co-authored by Dr. Jean-Charles Piette, who also had the highest scientific-research impact among the scholars in the field. •The co-citation network analysis revealed 11 highly connected clusters of RP research and indicated the "VEXAS Syndrome" as a key research area.

Errataetall:

ErratumIn: Clin Rheumatol. 2023 Oct 9;:. - PMID 37812324

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:42

Enthalten in:

Clinical rheumatology - 42(2023), 12 vom: 25. Dez., Seite 3201-3212

Sprache:

Englisch

Beteiligte Personen:

Cheng, Linlin [VerfasserIn]
Liu, Yongmei [VerfasserIn]
Ma, Qingqing [VerfasserIn]
Yan, Songxin [VerfasserIn]
Li, Haolong [VerfasserIn]
Zhan, Haoting [VerfasserIn]
Li, Zhan [VerfasserIn]
Li, Yongzhe [VerfasserIn]

Links:

Volltext

Themen:

Bibliometric analysis
Journal Article
Relapsing polychondritis
Review
VEXAS Syndrome
Web of Science

Anmerkungen:

Date Completed 13.11.2023

Date Revised 26.12.2023

published: Print-Electronic

ErratumIn: Clin Rheumatol. 2023 Oct 9;:. - PMID 37812324

Citation Status MEDLINE

doi:

10.1007/s10067-023-06741-2

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM361189338